Cargando…

Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy

In many clinical applications to evaluate the effect of a treatment, randomized control trials are difficult to carry out. On the other hand, clinical observational registries are often available and they contain longitudinal data regarding clinical parameters, drug therapies, and outcomes. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregorio, Caterina, Cappelletto, Chiara, Romani, Simona, Stolfo, Davide, Merlo, Marco, Barbati, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087972/
https://www.ncbi.nlm.nih.gov/pubmed/36058642
http://dx.doi.org/10.1002/bimj.202100003
_version_ 1785022470380584960
author Gregorio, Caterina
Cappelletto, Chiara
Romani, Simona
Stolfo, Davide
Merlo, Marco
Barbati, Giulia
author_facet Gregorio, Caterina
Cappelletto, Chiara
Romani, Simona
Stolfo, Davide
Merlo, Marco
Barbati, Giulia
author_sort Gregorio, Caterina
collection PubMed
description In many clinical applications to evaluate the effect of a treatment, randomized control trials are difficult to carry out. On the other hand, clinical observational registries are often available and they contain longitudinal data regarding clinical parameters, drug therapies, and outcomes. In the past, much research has addressed causal methods to estimate treatment effects from observational studies. In the context of time‐varying treatments, marginal structural models are often used. However, most analyses have focused on binary outcomes or time‐to‐the‐first event analyses. The novelty of our approach is to combine the marginal structural methodology with the case where correlated recurrent events and survival are the outcomes of interest. Our work focuses on solving the nontrivial problem of defining the measures of effect, specifying the model for the time‐dependent weights and the model to estimate the outcome, implementing them, and finally estimating the final treatment effects in this life‐history setting. Our approach provides a strategy that allows obtaining treatment effect estimates both on the recurrent events and the survival with a clear causal and clinical interpretation. At the same time, the strategy we propose is based on flexible modeling choices such as the use of joint models to capture the correlation within events from the same subject and the specification of time‐dependent treatment effects. The clinical problem which motivated our work is the evaluation of the treatment effect of beta‐blockers in arrhythmogenic right ventricular cardiomyopathy (ARVC/D), and the dataset comes from the Trieste Heart Muscle Disease Registry.
format Online
Article
Text
id pubmed-10087972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100879722023-04-12 Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy Gregorio, Caterina Cappelletto, Chiara Romani, Simona Stolfo, Davide Merlo, Marco Barbati, Giulia Biom J Clinical Biostatistics in the 2020s (ISCB 2020) In many clinical applications to evaluate the effect of a treatment, randomized control trials are difficult to carry out. On the other hand, clinical observational registries are often available and they contain longitudinal data regarding clinical parameters, drug therapies, and outcomes. In the past, much research has addressed causal methods to estimate treatment effects from observational studies. In the context of time‐varying treatments, marginal structural models are often used. However, most analyses have focused on binary outcomes or time‐to‐the‐first event analyses. The novelty of our approach is to combine the marginal structural methodology with the case where correlated recurrent events and survival are the outcomes of interest. Our work focuses on solving the nontrivial problem of defining the measures of effect, specifying the model for the time‐dependent weights and the model to estimate the outcome, implementing them, and finally estimating the final treatment effects in this life‐history setting. Our approach provides a strategy that allows obtaining treatment effect estimates both on the recurrent events and the survival with a clear causal and clinical interpretation. At the same time, the strategy we propose is based on flexible modeling choices such as the use of joint models to capture the correlation within events from the same subject and the specification of time‐dependent treatment effects. The clinical problem which motivated our work is the evaluation of the treatment effect of beta‐blockers in arrhythmogenic right ventricular cardiomyopathy (ARVC/D), and the dataset comes from the Trieste Heart Muscle Disease Registry. John Wiley and Sons Inc. 2022-09-04 2022-12 /pmc/articles/PMC10087972/ /pubmed/36058642 http://dx.doi.org/10.1002/bimj.202100003 Text en © 2022 The Authors. Biometrical Journal published by Wiley‐VCH GmbH. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Biostatistics in the 2020s (ISCB 2020)
Gregorio, Caterina
Cappelletto, Chiara
Romani, Simona
Stolfo, Davide
Merlo, Marco
Barbati, Giulia
Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title_full Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title_fullStr Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title_full_unstemmed Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title_short Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
title_sort using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: an application on arrhythmogenic cardiomyopathy
topic Clinical Biostatistics in the 2020s (ISCB 2020)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087972/
https://www.ncbi.nlm.nih.gov/pubmed/36058642
http://dx.doi.org/10.1002/bimj.202100003
work_keys_str_mv AT gregoriocaterina usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy
AT cappellettochiara usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy
AT romanisimona usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy
AT stolfodavide usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy
AT merlomarco usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy
AT barbatigiulia usingmarginalstructuraljointmodelstoestimatetheeffectofatimevaryingtreatmentonrecurrenteventsandsurvivalanapplicationonarrhythmogeniccardiomyopathy